Control of galactosylated glycoforms distribution in cell culture system

Biotechnology Progress

Volumn 30, Issue 3, 2014, Pages 547-553

  McCracken, Neil A ^a   Kowle, Ronald ^a   Ouyang, Anli ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Asparagine; Cell culture; Galactosylated glycosylation; Integral ammonium

Indexed keywords

AMINO ACIDS; CELL CULTURE; CELLS; GLYCOSYLATION; RECOMBINANT PROTEINS;

ASPARAGINE; CELL CULTURE PROCESS; CONTROL STRATEGIES; FOLLOW-UP STUDIES; GALACTOSYLTRANSFERASE; INTEGRAL AMMONIUM; INTRACELLULAR PH; OPERATION CONDITIONS;

PROCESS CONTROL;

AMMONIUM DERIVATIVE; ASPARAGINE; CULTURE MEDIUM; GALACTOSE; RECOMBINANT PROTEIN;

ANIMAL; BIOREACTOR; BIOSYNTHESIS; CHEMISTRY; CHO CELL LINE; CRICETULUS; CULTURE MEDIUM; CULTURE TECHNIQUE; GLYCOSYLATION; METABOLISM;

AMMONIUM COMPOUNDS; ANIMALS; ASPARAGINE; BIOREACTORS; CELL CULTURE TECHNIQUES; CHO CELLS; CRICETULUS; CULTURE MEDIA; GALACTOSE; GLYCOSYLATION; RECOMBINANT PROTEINS;

EID: 84922974254     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1906     Document Type: Article

References (33)

1. Reichert JM. Monoclonal antibodies as innovative therapeutics. Curr Pharm Biotechnol. 2008;9:426-430.
2. Lim A, Reed-Bogan A, Harmon B. Glycosylation profiling of a therapeutic recombinant monoclonal antibody with two N-linked glycosylation sites using liquid chromatography coupled to a hybrid quadrupole time-of-flight mass spectrometer. Anal Biochem. 2008;375:163-172.
3. He F, Hogan S, Latypov RF, Narhi LO, Razinkov VI. High throughput thermostability screening of monoclonal antibody formulations. J Pharm Sci. 2010;99:1707-1720.
4. Ghirlando R, Lund J, Goodall M, Jefferis R. Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry. Immunol Lett. 1999;68:47-52.
5. Jones AJ, Papac DI, Chin EH, Keck R, Baughman SA, Lin YS, Kneer J, Battersby JE. Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys. Glycobiology. 2007;17:529-540.
6. Keck R, Nayak N, Lerner L, Raju S, Ma S, Schreitmueller T, Chamow S, Moorhouse K, Kotts C, Jones A. Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine content. Biologicals. 2008;36:49-60.
7. Jassal R, Jenkins N, Charlwood J, Camilleri P, Jefferis R, Lund J. Sialylation of human IgG-Fc carbohydrate by transfected rat alpha2,6-sialyltransferase. Biochem Biophys Res Commun. 2001; 286:243-249.
8. Peipp M, Lammerts van Bueren JJ, Schneider-Merck T, Bleeker WW, Dechant M, Beyer T, Repp R, van Berkel PH, Vink T, van de Winkel JG, Parren PW, Valerius T. Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells. Blood. 2008;112:2390-2399.
9. Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K. The absence of fucose but not the presence of galactose or bisecting Nacetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 2003;278:3466-3473.
10. Jerreris R. Glycosylation as a strategy to improve antibodybased therapeutics. Nat Rev Drug Discov. 2009;8:226-234.
11. Boyd PN, Lines AC, Patel AK. The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. Mol Immunol. 1995;32:1311-1318.
12. Newkirk MM, Fournier MJ, Shiroky J. Rheumatoid factor avidity in patients with rheumatoid arthritis: identification of pathogenic RFs which correlate with disease parameters and with the gal(0) glycoform of IgG, J Clin Immunol. 1995;15:250-257.
13. Goochee CF, Gramer MJ, Andersen DC, Bahr JB, Rasmussen JR. The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties. Biotechnology (NY). 1991;9:1347-1355.
14. Nahrgang S. Influence of cell-line and process conditions on the glycosylation of recombinant proteins. [thesis]. Lausanne, Switzerland: École polytechnique fédérale de Lausanne; 2002.
15. Hossler P, Khattak S, Li1 Z. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology. 2009;19:936-949.
16. Pacis E, Yu M, Autsen J, Bayer R, Li F. Effects of cell culture conditions on antibody N-linked glycosylation-what affects high mannose 5 glycoform. Biotechnol Bioeng 2011;108:2348-2358.
17. Hayter PM, Curling EM, Gould ML, Baines AJ, Jenkins N, Salmon I, Strange PG, Bull AT. The effect of the dilution rate on CHO cell physiology and recombinant interferon-gamma production in glucose-limited chemostat culture. Biotechnol Bioeng. 1993;42:1077-1085.
18. Butler M. Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by mammalian cell systems. Cytotechnology. 2006;50:57-76.
19. Borys MC, Linzer DI, Papoutsakis ET. Culture pH affects expression rates and glycosylation of recombinant mouse placental lactogen proteins by Chinese hamster ovary (CHO) cells. Biotechnology (NY). 1993;11:720-724.
20. Andersen DC, Goochee CF. The effect of ammonia on the O-linked glycosylation of granulocyte colony-stimulating factor produced by Chinese hamster ovary cells. Biotechnol Bioeng. 1995;47:96-105.
21. Hong JK, Cho SM, Yoon SK. Substitution of glutamine by glutamate enhances production and galactosylation of recombinant IgG in Chinese hamster ovary cells. Appl Microbiol Biotechnol. 2010;88:869-876.
22. Zanghi JA, Schmelzer AE, Mendoza TP, Knop RH, Miller WM. Bicarbonate concentration and osmolality are key determinants in the inhibition of CHO cell polysialylation under elevated pCO2 or pH. Biotechnol Bioeng. 1999;65:182-191.
23. Kaufmann H, Mazur X, Fussenegger M, Bailey JE. Influence of low temperature on productivity, proteome and protein phosphorylation of CHO cells. Biotechnol Bioeng. 1999;63:573-582.
24. Kochanowski N, Blanchard F, Cacan R, Chirat F, Guedon E, Marc A, Goergen JL. IFN-c glycosylation macroheterogeneity, energetic cell status and medium composition during CHO cell cultures. Cells Culture. 2010;4:95-99.
25. Zhuang X, Pang X, Zhang W, Wu W, Zhao J, Yang H, Qu W. Effects of zinc and manganese on advanced glycation end products (AGEs) formation and AGEs-mediated endothelial cell dysfunction. Life Sci. 2012;90:131-139.
26. Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care. 1991;14:68-72.
27. Jain SK, Lim G. Lipoic acid decreases lipid peroxidation and protein glycosylation and increases (Na(1)1K(1))-and Ca(11)-ATPase activities in high glucose-treated human erythrocytes. Free Radic Biol Med. 2000;29:1122-1128.
28. Kurano N, Leist C, Messi F, Kurano S, Fiechter AJ. Growth behavior of Chinese hamster ovary cells in a compact loop bioreactor 2. Effects of medium components and waste products. J Biotechnol. 1990;15:113-128.
29. Zhou W, Chen C-C, Buckland B, Aunins J. Fed batch culture of NS0 myeloma cells with high antibody production. Biotechnol Bioeng. 1997;55:783-792.
30. Kim DY, Chaudhry MA, Kennard ML. Fed-Batch CHO cell t-PA production and feed glutamine replacement to reduce ammonia production. Biotechnol Prog. 2012;29:165-175.
31. Chen P, Harcum SW. Effects of amino acid additions on ammonium stressed CHO cells. J Biotechnol. 2005;117:277-286.
32. Zhou Q, Shankara S, Roy A, Qiu H, Estes S, McVie-Wylie A, Culm-Merdek K, Park A, Pan C, Edmunds T. Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function. Biotechnol Bioeng. 2008;99:652-665.
33. Chen P, Harcum SW. Effects of elevated ammonium on glycosylation gene expression in CHO cells. Metab Eng. 2006;8: 123-132.